nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyamemazine—HTR2A—Gilles de la Tourette syndrome	0.922	1	CbGaD
Cyamemazine—HTR2A—autonomic nervous system—Gilles de la Tourette syndrome	0.00335	0.312	CbGeAlD
Cyamemazine—HTR2C—Serotonin receptors—HTR2A—Gilles de la Tourette syndrome	0.0026	0.0463	CbGpPWpGaD
Cyamemazine—HTR2C—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00214	0.0381	CbGpPWpGaD
Cyamemazine—HTR2A—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00186	0.0331	CbGpPWpGaD
Cyamemazine—HTR2C—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00182	0.0325	CbGpPWpGaD
Cyamemazine—CHRM2—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00182	0.0325	CbGpPWpGaD
Cyamemazine—HTR2C—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00177	0.0316	CbGpPWpGaD
Cyamemazine—HTR2C—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—HTR2A—Gilles de la Tourette syndrome	0.00172	0.0307	CbGpPWpGaD
Cyamemazine—HTR2C—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00165	0.0294	CbGpPWpGaD
Cyamemazine—HTR2A—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00158	0.0282	CbGpPWpGaD
Cyamemazine—CHRM2—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00156	0.0277	CbGpPWpGaD
Cyamemazine—HTR2A—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00154	0.0274	CbGpPWpGaD
Cyamemazine—HTR2C—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00153	0.0273	CbGpPWpGaD
Cyamemazine—CHRM2—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00151	0.0269	CbGpPWpGaD
Cyamemazine—HTR2C—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00149	0.0265	CbGpPWpGaD
Cyamemazine—HTR2A—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00143	0.0255	CbGpPWpGaD
Cyamemazine—CHRM2—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00141	0.0251	CbGpPWpGaD
Cyamemazine—HTR2C—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00139	0.0247	CbGpPWpGaD
Cyamemazine—HTR2A—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00133	0.0237	CbGpPWpGaD
Cyamemazine—CHRM2—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00131	0.0233	CbGpPWpGaD
Cyamemazine—HTR2A—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00129	0.023	CbGpPWpGaD
Cyamemazine—CHRM2—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00127	0.0226	CbGpPWpGaD
Cyamemazine—HTR2A—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0012	0.0215	CbGpPWpGaD
Cyamemazine—CHRM2—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00118	0.0211	CbGpPWpGaD
Cyamemazine—HTR2C—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00116	0.0206	CbGpPWpGaD
Cyamemazine—HTR2C—midbrain—Gilles de la Tourette syndrome	0.00103	0.0956	CbGeAlD
Cyamemazine—CHRM2—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.000985	0.0176	CbGpPWpGaD
Cyamemazine—HTR2C—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000971	0.0173	CbGpPWpGaD
Cyamemazine—CHRM2—nervous system—Gilles de la Tourette syndrome	0.000875	0.0816	CbGeAlD
Cyamemazine—HTR2C—nervous system—Gilles de la Tourette syndrome	0.000844	0.0786	CbGeAlD
Cyamemazine—CHRM2—central nervous system—Gilles de la Tourette syndrome	0.000843	0.0785	CbGeAlD
Cyamemazine—CHRM2—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000828	0.0148	CbGpPWpGaD
Cyamemazine—HTR2C—central nervous system—Gilles de la Tourette syndrome	0.000812	0.0757	CbGeAlD
Cyamemazine—HTR2A—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.000704	0.0125	CbGpPWpGaD
Cyamemazine—CHRM2—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.000691	0.0123	CbGpPWpGaD
Cyamemazine—HTR2A—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.000683	0.0122	CbGpPWpGaD
Cyamemazine—CHRM2—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.000671	0.012	CbGpPWpGaD
Cyamemazine—CHRM2—brain—Gilles de la Tourette syndrome	0.000669	0.0623	CbGeAlD
Cyamemazine—HTR2C—brain—Gilles de la Tourette syndrome	0.000645	0.0601	CbGeAlD
Cyamemazine—HTR2A—midbrain—Gilles de la Tourette syndrome	0.000515	0.048	CbGeAlD
Cyamemazine—Acetophenazine—DRD2—Gilles de la Tourette syndrome	0.000512	0.0459	CrCbGaD
Cyamemazine—CHRM2—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.000438	0.0078	CbGpPWpGaD
Cyamemazine—HTR2A—nervous system—Gilles de la Tourette syndrome	0.000423	0.0394	CbGeAlD
Cyamemazine—HTR2A—central nervous system—Gilles de la Tourette syndrome	0.000408	0.038	CbGeAlD
Cyamemazine—Mesoridazine—DRD3—Gilles de la Tourette syndrome	0.000398	0.0358	CrCbGaD
Cyamemazine—Propiomazine—DRD4—Gilles de la Tourette syndrome	0.000389	0.0349	CrCbGaD
Cyamemazine—Prochlorperazine—DRD3—Gilles de la Tourette syndrome	0.000386	0.0346	CrCbGaD
Cyamemazine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000352	0.00628	CbGpPWpGaD
Cyamemazine—Fluphenazine—DRD3—Gilles de la Tourette syndrome	0.000349	0.0313	CrCbGaD
Cyamemazine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000342	0.00609	CbGpPWpGaD
Cyamemazine—Methotrimeprazine—DRD4—Gilles de la Tourette syndrome	0.000333	0.0299	CrCbGaD
Cyamemazine—HTR2A—brain—Gilles de la Tourette syndrome	0.000324	0.0301	CbGeAlD
Cyamemazine—CHRM2—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000323	0.00577	CbGpPWpGaD
Cyamemazine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000318	0.00568	CbGpPWpGaD
Cyamemazine—Chlorprothixene—DRD3—Gilles de la Tourette syndrome	0.000318	0.0285	CrCbGaD
Cyamemazine—CHRM2—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000314	0.0056	CbGpPWpGaD
Cyamemazine—Triflupromazine—DRD2—Gilles de la Tourette syndrome	0.000314	0.0282	CrCbGaD
Cyamemazine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000306	0.00545	CbGpPWpGaD
Cyamemazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000302	0.00538	CbGpPWpGaD
Cyamemazine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.0003	0.00535	CbGpPWpGaD
Cyamemazine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000297	0.00529	CbGpPWpGaD
Cyamemazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000293	0.00522	CbGpPWpGaD
Cyamemazine—CHRM2—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.000292	0.00521	CbGpPWpGaD
Cyamemazine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000291	0.00519	CbGpPWpGaD
Cyamemazine—Acepromazine—DRD2—Gilles de la Tourette syndrome	0.00029	0.0261	CrCbGaD
Cyamemazine—HTR2C—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.000288	0.00514	CbGpPWpGaD
Cyamemazine—Promazine—DRD4—Gilles de la Tourette syndrome	0.000288	0.0259	CrCbGaD
Cyamemazine—Methotrimeprazine—DRD3—Gilles de la Tourette syndrome	0.000287	0.0258	CrCbGaD
Cyamemazine—CHRM2—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.000284	0.00507	CbGpPWpGaD
Cyamemazine—Thioproperazine—DRD2—Gilles de la Tourette syndrome	0.000284	0.0255	CrCbGaD
Cyamemazine—Pipotiazine—DRD2—Gilles de la Tourette syndrome	0.000279	0.0251	CrCbGaD
Cyamemazine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000276	0.00493	CbGpPWpGaD
Cyamemazine—Mesoridazine—DRD2—Gilles de la Tourette syndrome	0.000276	0.0247	CrCbGaD
Cyamemazine—Trimipramine—SLC6A3—Gilles de la Tourette syndrome	0.000273	0.0245	CrCbGaD
Cyamemazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000273	0.00486	CbGpPWpGaD
Cyamemazine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000271	0.00484	CbGpPWpGaD
Cyamemazine—Prochlorperazine—DRD2—Gilles de la Tourette syndrome	0.000267	0.024	CrCbGaD
Cyamemazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000262	0.00467	CbGpPWpGaD
Cyamemazine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.000258	0.0046	CbGpPWpGaD
Cyamemazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000257	0.00458	CbGpPWpGaD
Cyamemazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000254	0.00453	CbGpPWpGaD
Cyamemazine—Chlorpromazine—DRD4—Gilles de la Tourette syndrome	0.000254	0.0228	CrCbGaD
Cyamemazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00025	0.00445	CbGpPWpGaD
Cyamemazine—Fluphenazine—DRD2—Gilles de la Tourette syndrome	0.000241	0.0217	CrCbGaD
Cyamemazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000237	0.00422	CbGpPWpGaD
Cyamemazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000233	0.00415	CbGpPWpGaD
Cyamemazine—Propiomazine—DRD2—Gilles de la Tourette syndrome	0.000232	0.0208	CrCbGaD
Cyamemazine—HTR2C—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00023	0.00409	CbGpPWpGaD
Cyamemazine—Acepromazine—HTR2A—Gilles de la Tourette syndrome	0.000224	0.0201	CrCbGaD
Cyamemazine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000223	0.00397	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000223	0.00397	CbGpPWpGaD
Cyamemazine—Chlorprothixene—DRD2—Gilles de la Tourette syndrome	0.00022	0.0197	CrCbGaD
Cyamemazine—Thioproperazine—HTR2A—Gilles de la Tourette syndrome	0.000219	0.0197	CrCbGaD
Cyamemazine—Chlorpromazine—DRD3—Gilles de la Tourette syndrome	0.000219	0.0196	CrCbGaD
Cyamemazine—Pipotiazine—HTR2A—Gilles de la Tourette syndrome	0.000216	0.0194	CrCbGaD
Cyamemazine—Mesoridazine—HTR2A—Gilles de la Tourette syndrome	0.000213	0.0191	CrCbGaD
Cyamemazine—Thioridazine—DRD2—Gilles de la Tourette syndrome	0.000208	0.0187	CrCbGaD
Cyamemazine—HTR2C—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000208	0.0037	CbGpPWpGaD
Cyamemazine—Trimipramine—DRD2—Gilles de la Tourette syndrome	0.000203	0.0182	CrCbGaD
Cyamemazine—Imipramine—SLC6A3—Gilles de la Tourette syndrome	0.000203	0.0182	CrCbGaD
Cyamemazine—HTR2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000199	0.00356	CbGpPWpGaD
Cyamemazine—Methotrimeprazine—DRD2—Gilles de la Tourette syndrome	0.000199	0.0178	CrCbGaD
Cyamemazine—CHRM2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000196	0.00349	CbGpPWpGaD
Cyamemazine—Promethazine—DRD2—Gilles de la Tourette syndrome	0.000196	0.0176	CrCbGaD
Cyamemazine—HTR2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000194	0.00345	CbGpPWpGaD
Cyamemazine—Trifluoperazine—DRD2—Gilles de la Tourette syndrome	0.000193	0.0173	CrCbGaD
Cyamemazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000191	0.00341	CbGpPWpGaD
Cyamemazine—Perphenazine—DRD2—Gilles de la Tourette syndrome	0.000191	0.0171	CrCbGaD
Cyamemazine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00019	0.00339	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00019	0.00339	CbGpPWpGaD
Cyamemazine—Fluphenazine—HTR2A—Gilles de la Tourette syndrome	0.000187	0.0167	CrCbGaD
Cyamemazine—HTR2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00018	0.00322	CbGpPWpGaD
Cyamemazine—Propiomazine—HTR2A—Gilles de la Tourette syndrome	0.000179	0.0161	CrCbGaD
Cyamemazine—CHRM2—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000177	0.00316	CbGpPWpGaD
Cyamemazine—Promazine—DRD2—Gilles de la Tourette syndrome	0.000172	0.0154	CrCbGaD
Cyamemazine—Clomipramine—HTR2A—Gilles de la Tourette syndrome	0.000171	0.0153	CrCbGaD
Cyamemazine—Chlorprothixene—HTR2A—Gilles de la Tourette syndrome	0.00017	0.0152	CrCbGaD
Cyamemazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000163	0.0029	CbGpPWpGaD
Cyamemazine—Thioridazine—HTR2A—Gilles de la Tourette syndrome	0.000161	0.0144	CrCbGaD
Cyamemazine—Trimipramine—HTR2A—Gilles de la Tourette syndrome	0.000157	0.0141	CrCbGaD
Cyamemazine—Methotrimeprazine—HTR2A—Gilles de la Tourette syndrome	0.000153	0.0138	CrCbGaD
Cyamemazine—Chlorpromazine—DRD2—Gilles de la Tourette syndrome	0.000151	0.0136	CrCbGaD
Cyamemazine—Promethazine—HTR2A—Gilles de la Tourette syndrome	0.000151	0.0136	CrCbGaD
Cyamemazine—Imipramine—DRD2—Gilles de la Tourette syndrome	0.000151	0.0135	CrCbGaD
Cyamemazine—Trifluoperazine—HTR2A—Gilles de la Tourette syndrome	0.000149	0.0134	CrCbGaD
Cyamemazine—Perphenazine—HTR2A—Gilles de la Tourette syndrome	0.000147	0.0132	CrCbGaD
Cyamemazine—HTR2C—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000145	0.00259	CbGpPWpGaD
Cyamemazine—Promazine—HTR2A—Gilles de la Tourette syndrome	0.000133	0.0119	CrCbGaD
Cyamemazine—HTR2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00013	0.00231	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000126	0.00225	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000124	0.00221	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000118	0.0021	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000117	0.00209	CbGpPWpGaD
Cyamemazine—Chlorpromazine—HTR2A—Gilles de la Tourette syndrome	0.000117	0.0105	CrCbGaD
Cyamemazine—Imipramine—HTR2A—Gilles de la Tourette syndrome	0.000116	0.0105	CrCbGaD
Cyamemazine—HTR2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000114	0.00204	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000113	0.00201	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000111	0.00197	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000109	0.00195	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000107	0.00192	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000107	0.0019	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000102	0.00182	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000102	0.00182	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.0001	0.00179	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.0001	0.00178	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	9.94e-05	0.00177	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	9.76e-05	0.00174	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	9.26e-05	0.00165	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	9.09e-05	0.00162	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	8.22e-05	0.00147	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	7.46e-05	0.00133	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	7.01e-05	0.00125	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	6.96e-05	0.00124	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	6.76e-05	0.0012	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	6.36e-05	0.00113	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	6.3e-05	0.00112	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	6.05e-05	0.00108	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	5.94e-05	0.00106	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	5.87e-05	0.00105	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	5.76e-05	0.00103	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	5.47e-05	0.000975	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	5.37e-05	0.000957	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	4.41e-05	0.000786	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	3.76e-05	0.00067	CbGpPWpGaD
